Background: Metastatic spread poses the greatest challenge for the management of Prostate Cancer (PCa). Although its frequency at diagnosis of PCa cases is only 4%, it is associated with poor prognosis, with five year survival rates of only 30%. Molecular mechanisms involved in metastatic progression are not completely understood; however, it has been noted that chemokines and their receptors play a key role in the establishment of metastatic lesions.

Objective: To compare the mRNA expression profiles of chemokines and their receptors in two human PCa cell lines with different metastatic phenotypes (LNCaP, PC-3) and in a control, normal prostate epithelial cell line (PWR-1E).

Methods: We evaluated the expression profiles at the transcript level of chemokines and their receptors in LNCaP, PC-3 and PWR-1E human cell lines using a commercial primer panel (Chemokines SensiMix qPCR Primers Panel©,Origene Technologies), as well as a custom primer panel. The relative quantification of gene expression was determined using the ΔΔCt method with the normal PWR-1E cell line as the reference cell line and normalizing the expression to β-actin, HPRT1 and GAPDH housekeeping genes.

Results: Sixteen gene transcripts were overexpressed in PC-3, 13 of which were exclusively overexpressed in this cell line and 3 other genes were up-regulated in both PC-3 and LNCaP cell lines. Of the 13 genes overexpressed in PC-3, 12 were found under-expressed in LNCaP cell line, compared to PWR-1E (CCL2, CCL26, CCL28, CXCL2, CXCL3, CXCL4, CXCL4V1, CXCL6, IL8, CXCL12, CCR10, and CCRL2). Chemokine transcript under-expression was more frequently found in LNCaP than in PC-3 (11 vs 8) and transcripts for genes CCL3, CCL3L1, CCL3L3, CCL27 and DARC were underexpressed in both cell lines.

Discussion: Here we describe the differential chemokine expression profile between PCa cell lines with different metastatic potentials. In addition to chemokines/receptors known to play a role in PCa, we have identified the differential expression of chemokine gene transcripts not previously associated with PCa.

Conclusions: Differential chemokine expression at the mRNA level was found in association with metastatic phenotypes of PCa cell lines. Additional research is needed to determine mechanisms involved in genic regulation of this profiles and to determine their roles in tumorigenesis and cancer progression in the prostate.

Financial support: Colciencias Contract #462-2008

Citation Format: Niradiz Reyes, Alfonso Bettin, Juan Rebollo, Oscar Correa, Jan Geliebter. Chemokine expression profile in prostate cancer cell lines: Association with metastatic potential. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2691. doi:10.1158/1538-7445.AM2013-2691

1.
Clarke NW, Hart CA Brown MD.Molecular mechanisms of metastasis in prostate cancer.
Asian J Androl.
2009 Jan
;
11
(
1
):
57
–67.
2.
Thobe MN, Clark RJ, Bainer RO, Prasad SM Rinker-Schaeffer CW.From Prostate to Bone. Cancers (Basel). 
2011
;
3
(
1
):
478
–93.
3.
Bendas G Borsig L.Cancer cell adhesion and metastasis:selectins, integrins, and the inhibitory potential of heparins.
Int J Cell Biol.
2012
;
2012
:676731.